Novo Nordisk Investigational Site
Plainsboro, New Jersey, 08536, United States
NCT Number: NCT00121355
This trial is conducted in the United States of America (USA). The aim of this trial is to examine whether nurses prefer to use the NovoFine® Autocover Needle or the BD Safety Glide (TM) Syringe (only) in a hospital setting. The number of needle stick injuries will also be evaluated and whether these hospital nurses prefer the safety features of the NovoFine® Autocover Needle versus those of the BD Safety Glide (TM) Syringe. The identified hospital nurses will evaluate the two types of needles during standard administration of insulin to patients being treated for diabetes.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Plainsboro, New Jersey, 08536, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Novo Nordisk A/S
Industry
An Open-Label, Multi-Center, Prospective Cross-Over Study of Preference and Safety of NovoFine® Autocover(TM) Needles Compared to BD Safety Glide (TM) Syringes in the Hospital Setting
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01024218
Delivery Systems, Diabetes
Copenhagen, Denmark
View Trial DetailsNCT00872560
Autoimmune Diseases, Delivery Systems
Chieti, Italy
View Trial DetailsNCT00773279
Autoimmune Diseases, Delivery Systems
Burlingame, California, United States
View Trial DetailsNCT01680328
Autoimmune Diseases, Delivery Systems
Neuss, Germany
View Trial Details